Vienna, Austria

ESTRO 2023

Session Item

Sunday
May 14
08:45 - 10:00
Lehar 1-3
ESTRO-AAPM: Big data, big headache
Catharine Clark, United Kingdom;
Kristy Brock, USA
2130
Joint Symposium
Physics
08:45 - 08:57
Dealing with legacy treatment data
Lydia Wilson, USA
SP-0366

Abstract

Dealing with legacy treatment data
Authors:

Lydia Wilson1, Abigail Bryce-Atkinson2, Fakhriddin Pirlepesov1, Fang Xie1, Austin Faught1, Marianne Aznar2, Marcel van Herk2, Eliana Vasquez Osorio2

1St. Jude Children's Research Hospital, Radiation Oncology, Memphis, USA; 2University of Manchester, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester, United Kingdom

Show Affiliations
Abstract Text

Legacy treatment data are a necessary evil for many radiotherapy researchers. Legacy data are images, structure contours, and dose distributions associated with treatment plans that were created, and are likely still stored in historical, retired treatment planning systems. Legacy data are commonly required by those looking to study the link between radiotherapy exposures and late effects with long latency periods of years to decades. Other researchers, however, may also find themselves considering the prospect of resurrecting legacy data to bolster cohort numbers when studying rare diseases and/or effects, or to improve data variety for advanced analytical techniques like data mining and deep learning. Despite their value, working with legacy data can be intimidating and onerous.

We at St. Jude Children’s Research Hospital have found it necessary to leverage treatment data created as many as 25 years ago for all of the above-mentioned reasons. Our journey to recover and employ legacy data involved inconsistent software versions, outdated data formats, questionable data veracity, database crashes, and many other hurdles. This presentation will draw on our experiences and focus on the challenges associated with retrieving and using legacy treatment data, as well as strategies to overcome them. The objective will be to provide attendees with: realistic expectations for working with legacy treatment data, appreciation for the value of legacy treatment data, and strategies for overcoming, or avoiding entirely, some potential obstacles.